In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection

참고문헌 (8)

1. Nannini E, "Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus", Curr Opin Pharmacol, 10, pp.516~521 (2010)
2. Narita M, "Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome", Pharmacotherapy, 27, pp.1189~1197 (2007)
3. Lewis PO, "Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia", J Clin Pharm Ther, 43, pp.614~625 (2018)
4. Yu So Hyun, "Ten-Year Prevalence Trends of Phenotypically Identified Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Clinical Specimens", Annals of Laboratory Medicine, 41(4), pp.386~393 (2021), 대한진단검사의학회[DOI]
5. Cho YS, "Multiple-dose safety, tolerability, pharmacokinetics, and pharmacodynamics of oral LCB01-0371 in healthy male volunteers", Clin Ther, 40, pp.2050~2064 (2018)
6. Jeong JW, "In vitro and in vivo activities of LCB01-0371, a new oxazolidinone", Antimicrob Agents Chemother, 54, pp.5359~5362 (2010)
7. Zong Z, "Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China", Antimicrob Agents Chemother, 62, pp.e00165-18~ (2018)
8. CLSI, "Performance standards for antimicrobial susceptibility testing, M100. 31th ed", Clinical and Laboratory Standards Institute, ~ (2021)

관련 논문AI추천